Xeris Biopharma Holdings, Inc. (XERS)
NASDAQ: XERS · Real-Time Price · USD
3.750
-0.220 (-5.54%)
At close: Feb 21, 2025, 4:00 PM
3.760
+0.010 (0.27%)
After-hours: Feb 21, 2025, 5:59 PM EST
Xeris Biopharma Holdings Employees
Xeris Biopharma Holdings had 377 employees as of December 31, 2023. The number of employees increased by 22 or 6.20% compared to the previous year.
Employees
377
Change (1Y)
22
Growth (1Y)
6.20%
Revenue / Employee
$496,979
Profits / Employee
-$167,408
Market Cap
559.06M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
XERS News
- 17 days ago - Xeris to Participate in Upcoming Investor Conferences - Business Wire
- 4 weeks ago - The American Diabetes Association and Xeris Pharmaceuticals Announce National Collaboration to Provide Life-Saving Hypoglycemia Education and Awareness - PRNewsWire
- 6 weeks ago - Xeris Expects to Exceed Full-Year 2024 Financial Guidance - Business Wire
- 6 weeks ago - Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - Business Wire
- 3 months ago - Xeris to Participate in Piper Sandler 36th Annual Healthcare Conference - Business Wire
- 3 months ago - Xeris Biopharma Holdings, Inc. (XERS) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Xeris Biopharma Reports Third Quarter 2024 Financial Results - Business Wire
- 4 months ago - Xeris Biopharma to Report Third Quarter 2024 Financial Results on November 8, 2024 - Business Wire